Loading page
Loading page
Loading substance route
These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.
1P-ETH-LAD is not habit-forming and the desire to use it can actually decrease with use. Like most psychedelics, it is considered self-regulating rather than self-reinforcing.
The exact toxic dose is unknown. Very little data exists about the pharmacological properties, metabolism, and toxicity of 1P-ETH-LAD due to its limited history of human usage.
Delusions are listed among possible cognitive effects during the experience. No quantified data exists on standalone psychosis risk.
1P-ETH-LAD emerged on the research chemical market in early 2016, with virtually no documented history of human usage prior to January of that year. The compound appeared alongside other novel lysergamide derivatives such as 1P-LSD and ETH-LAD, marketed primarily through online research chemical…
Controlled as a Schedule III substance under the Precursor Control Regulations of the Controlled Drugs and Substances Act. This classification restricts production, distribution, and import.
Classified as a controlled substance as a defined derivative of lysergic acid under Verzeichnis E point 263 of the narcotics scheduling. An exemption exists for legitimate scientific or industrial applications.
Prohibited under the Psychoactive Substances Act 2016, which came into effect on May 26, 2016. Production, supply, and import are criminal offenses. Personal possession is not criminalized under this legislation, though intent to supply remains prosecutable.
Controlled under the Neue-psychoaktive-Stoffe-Gesetz (New Psychoactive Substances Act) as of July 18, 2019. Production, import with intent to distribute, administration to others, and trading are punishable offenses. Personal possession is prohibited but not subject to criminal penalties.
Classified as a controlled drug. Possession, production, supply, and import are all prohibited under national drug legislation.
Not explicitly scheduled at the federal level. However, when sold or possessed for human consumption, it may be prosecuted under the Federal Analogue Act as a substantially similar compound to scheduled lysergamides such as LSD.
14 sources cited